Navigation Links
Methylphenidate 'normalizes' activation in key brain areas in kids with ADHD
Date:5/9/2013

Philadelphia, Pa. (May 9, 2013) The stimulant drug methylphenidate "normalizes" activation of several brain areas in young patients with attention-deficit/hyperactivity disorder (ADHD), according to a review published in the May Harvard Review of Psychiatry. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

Studies using functional magnetic resonance imaging (fMRI) show increased activation of key brain areas after a dose of methylphenidate in young patients with ADHD, according to the systematic review by Constance A. Moore, PhD, and colleagues of the University of Massachusetts Medical School. They write, "In most cases, this increase 'normalized' activation of at least some brain areas to levels seen in typically developing children."

How Do ADHD Medications Affect the Brain in ADHD Patients?

In a research review, Dr Moore and colleagues identified nine previous studies using fMRI to study patterns of brain activation in response to a single dose of methylphenidate. Perhaps best known by the brand name Ritalin, methylphenidate is a common and effective treatment for ADHD. "Although methylphenidate has been shown to significantly improve the behavioral symptoms associated with ADHD, both the mechanism behind its therapeutic effect and its direct effects on brain function are unknown," the researchers write.

The studies evaluated methylphenidate-induced fMRI changes in various brain areas, as the participants performed different types of tasks. Most of the studies included adolescent boys with ADHD, along with matched groups of young people without ADHD.

Methylphenidate altered activation patterns in widely distributed areas of the brain in ADHD patients, the results showed. The main brain areas involved were the frontal lobes, the basal ganglia, and cerebellum: "Abnormalities in these regions have all been implicated in patients with ADHD," Dr Moore and coauthors write.

Different areas were activated during different types of fMRI tasks. Several studies assessed performance on "inhibitory control" tasksthe ability to control certain types of accustomed ("prepotent") responses. In three out of five studies, methylphenidate "at least partially normalized" brain activation in ADHD patients, compared to healthy young people.

Different Tasks Affect Different Brain Areas

A few studies showed similar normalization of brain responses with methylphenidate on tasks of selective attention and time perceptionalthough not on tasks evaluating working memory. Methylphenidate mainly affected activation in the frontal lobes during inhibitory control tasks. During selective attention tasks, a wider range of brain areas were affected.

Since none of the studies evaluated ADHD symptoms on and off methylphenidate, there was no way to link the changes in brain activation with clinical improvement. Brain activation patterns with methylphenidate differed for patients who were versus were not previously treated with stimulants for ADHD.

Patients with ADHD have "age-inappropriate frequency or severity of inattentive or hyperactive-impulsive behaviors," according to the authors. It affects about five percent of children worldwide, and a growing body of evidence suggests that ADHD persists throughout adolescence and into adulthood. Functional fMRI provides a safe, noninvasive way to study how stimulants like methylphenidate may act in the brain of ADHD patients.

The new analysis suggests that methylphenidate partially normalizes activation in key brain areas thought to be involved in ADHD. The studies "may provide evidence that methylphenidate facilitates the return of brain function in ADHD patients to, or close to, a typically functioning state," Dr Moore and colleagues write. They call for further research to confirm that methylphenidate-induced changes in specific brain areas are correlated with improvement in ADHD symptoms.


'/>"/>

Contact: Connie Hughes
connie.hughes@wolterskluwer.com
646-674-6348
Wolters Kluwer Health
Source:Eurekalert

Related medicine news :

1. Girls with eating disorders regain healthy fatty acid levels when their weight normalizes
2. Research reveals new understanding of X chromosome inactivation
3. HPV in older women may be due to reactivation of virus, not new infection
4. Same protein that fires up cancer-promoting Erk also blocks its activation
5. Study Suggests Vaccine May Help Kids With Brain Cancer
6. Epilepsy Leads to More Brain Abnormalities Over Time
7. UCLA Brain Injury Research Center gets NCAA funding for research on sports concussions
8. Why is traumatic brain injury increasing among the elderly?
9. Brain Falters Near End of Life, but Games, Puzzles Might Slow Decline
10. Dental X-Rays May Be Linked to Benign Brain Tumors
11. Nonsurgical Method to Measure Brain Pressure Shows Promise
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... 2017 , ... The doctors at Wall Centre Dental are now expanding their ... require sedation to receive dental care. The doctors offer three treatment options to put ... to oral surgery, at their dental office in Vancouver. Wall Centre Dental is currently ...
(Date:4/25/2017)... ... April 25, 2017 , ... As Spring reignites vigilance ... research related to Zika virus during pregnancy, as well as other prenatal exposures ... science. , The Teratology Society is an international and multidisciplinary ...
(Date:4/25/2017)... ... April 25, 2017 , ... Somnoware, ... to its patient care management module. Using this new feature, sleep physicians can ... been initiated on continuous positive airway pressure (CPAP), oral, or other forms of ...
(Date:4/25/2017)... ... April 25, 2017 , ... Amendia, Inc., designer, developer, ... strategic partnership with and platinum sponsorship of Global Spine Outreach (“GSO”), a charitable ... management of complex spine deformity cases, particularly in children. , GSO’s focus is ...
(Date:4/24/2017)... ... April 24, 2017 , ... The Santana Telehealth Project was honored ... 2.0 — the American Telemedicine Association’s annual conference, on April 23 in Orlando, FL. ... telemedicine to improve the lives of the poor and underserved in other parts of ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 20, 2017  Cogentix Medical, Inc. (NASDAQ: CGNT), ... the Urology, Uro/Gyn and Gynecology markets with innovative ... has joined the Company as Senior Vice President, ... position, Mr. Keswani will report directly to ... "Our organization is delighted that Ash has joined ...
(Date:4/20/2017)... Research and Markets has announced the addition of the "Global ... and Increasing Usage of Complex Biologics during the Forecast Period" ... The ... Billion in 2015 to around USD 26 Billion by 2020. ... Rapidly Expanding Injectables Market and Increasing Usage of Complex Biologics during ...
(Date:4/20/2017)... 2017 Eyevensys, a private biotechnology ... gene expression technology that enables the safe, local, sustained ... a wide range of ophthalmic diseases, announces it has ... Regulatory Agency (MHRA) to advance its technology into clinical ... The ...
Breaking Medicine Technology: